Devgen NV Drug Candidates May Promise Breakthrough In The Treatment Of Rheumatoid Arthritis And Other Inflammatory Diseases

Devgen (Euronext Brussels: DEVG) announced today that, following encouraging results from studies in animals, one of its preclinical programs may show promise for the treatment of inflammatory diseases.